Pelvic & vaginal health

Bladder Medications and Memory: Weighing the Risk

Save

Older anticholinergic bladder medications can cloud memory, especially in later life, and long-term use has been linked to higher dementia risk in observational studies, though not proven to cause it. Newer beta-3 agonists and non-drug options avoid that concern, making this a decision to weigh with a clinician.

Last updated: July 2026

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

Can bladder control pills affect your memory?

Some bladder medications can affect thinking, but the answer depends heavily on which drug and which person. Two main classes treat an overactive bladder: older anticholinergics, such as oxybutynin, and newer beta-3 agonists, such as mirabegron 1. The memory concern applies mainly to the anticholinergics, and mostly in older adults. Overactive bladder affects up to 1 in 4 women and more than 1 in 3 women over age 60, so these drugs are widely used 2. According to a federal systematic review, both classes reduce leaks and urgency by similar, modest amounts, so effectiveness alone rarely settles the choice 1. That is why ACOG's practice guideline recommends caution with anticholinergics in older women 2.

How do anticholinergic bladder medications work?

Anticholinergic medicines calm an overactive bladder by blocking a nerve messenger called acetylcholine. That same messenger is used throughout the body and brain, which is why these drugs can cause dry mouth, constipation, blurred vision, and drowsiness, and, in some people, slowed thinking or confusion. Older adults are more sensitive because the aging brain has less acetylcholine to spare and clears drugs more slowly 1.

The practical fallout shows up in how people use them. A federal review found that side effects drive many women to stop anticholinergics, often within 12 months of starting 1. The degree of effect also varies by drug, since some cross into the brain more readily than others, and formulations differ in how much reaches the bloodstream 2.

What does the research actually say about dementia risk?

Observational studies have linked years of heavy anticholinergic use to a higher risk of dementia, but they cannot prove cause and effect. These studies pool many anticholinergic drugs, for bladder, allergies, depression, and sleep, so bladder pills are only one slice of a person's total exposure. People who take more of these medicines may also differ in other ways that affect dementia risk.

What the signal does suggest is that cumulative, long-term burden matters more than an occasional dose. This is why clinicians increasingly tally a person's total anticholinergic load and, when it is high, look for lower-risk substitutes, a caution echoed in ACOG's guidance for older women 2. Short-term use for a flare is a much smaller exposure than years of daily use.

What are the lower-risk alternatives?

Beta-3 agonists and non-drug approaches sidestep the anticholinergic concern entirely. Mirabegron and similar beta-3 agonists relax the bladder through a different pathway, so they do not block acetylcholine and are often preferred when memory or anticholinergic burden is a worry 1. Behavioral care works as well or better for many women and carries no cognitive risk: bladder training, pelvic floor exercises, weight management, and adjusting fluids and caffeine, with benefits building over about 6 to 12 weeks 3. In pooled trials, women who did pelvic floor physical therapy were about eight times more likely to report their leaks were cured 3. Urgency often first appears around perimenopause and rises with age, the very years when limiting anticholinergic burden matters most 1.

When bladder medication choices need a clinician

Choosing, changing, or stopping a bladder medication is a decision to make with a clinician who can see your whole medication list. Many everyday drugs, for allergies, sleep, and mood, also carry anticholinergic effects, and it is the total load that matters most, especially after age 65. A clinician can tally that burden, weigh a beta-3 agonist or treatment for urinary incontinence without medication, and adjust safely rather than changing things abruptly. New confusion or memory changes after a medication starts are worth reporting promptly. Gale can help you list your medicines and questions before that conversation.

Common questions

No. The concern centers on older anticholinergic drugs like oxybutynin, and mainly in older adults or with long-term use. Newer beta-3 agonists such as mirabegron work through a different pathway and are not tied to the same memory concern.

The evidence does not show that. The dementia signal comes from observational studies of high, cumulative use over years, and those studies cannot prove the drugs are the cause. Short courses are a much smaller exposure, and a clinician can help weigh the overall picture.

Options include beta-3 agonist medications and non-drug approaches like bladder training, pelvic floor exercises, weight management, and adjusting caffeine and fluids. Many women do as well or better with these, and they carry no cognitive risk. A clinician can help match an option to your situation.

A clinician or pharmacist can review your full list, since drugs for allergies, sleep, and mood can also add anticholinergic effects. They can total the burden and suggest lower-risk swaps where it makes sense, rather than changing anything on your own.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

A primary-care clinician

Gale can help you find one in your state and request a visit.

Find care →

When a bladder medication needs clinician review

  • —New confusion, memory changes, or hallucinations after starting a bladder medication are a reason to seek prompt clinician review.
  • —Being unable to urinate, a severely distended belly, or severe constipation is a reason to seek same-day medical care.
  • —New falls, unsteadiness, or heavy daytime drowsiness on a bladder medicine are a reason to review the regimen with a clinician.
  • —Taking several medicines with anticholinergic effects at once is a reason to ask a clinician or pharmacist to review your total load.
  • —Blood in the urine or new pelvic pain is a reason to seek clinician evaluation.

This article is general health education, not medical advice. Whether a bladder medication is right for you, and which one, is a decision to make with a prescribing clinician or pharmacist who knows your full medication list.

References

  1. 1.Balk E, Adam GP, Kimmel H, Rofeberg V, Saeed I, Jeppson P, Trikalinos T (2018). Nonsurgical Treatments for Urinary Incontinence in Women: A Systematic Review Update. Agency for Healthcare Research and Quality (AHRQ). PMID 30516945 ✓Systematic review comparing nonsurgical treatments for urinary incontinence, including similar modest effectiveness of anticholinergics and beta-3 agonists, their adverse effects, and high discontinuation from side effects.
  2. 2.American College of Obstetricians and Gynecologists (2015). ACOG Practice Bulletin No. 155: Urinary Incontinence in Women. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000001148 ✓Practice bulletin on urinary incontinence in women, including pharmacotherapy options and the recommendation to use anticholinergic drugs cautiously in older women.
  3. 3.Dumoulin C, Cacciari LP, Hay-Smith EJC (2018). Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD005654.pub4 ✓Pooled trial evidence that pelvic floor muscle training substantially improves and can cure urinary incontinence, supporting non-drug care as an effective alternative.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library